| Autor: |
Shanazarov, N. A., Seidalin, N. K., Khalirahmanov, A. F., Gatiyatullina, G. D., Zinchenko, S. V., Idrisova, K. F. |
| Předmět: |
|
| Zdroj: |
Systematic Reviews in Pharmacy; 2020, Vol. 11 Issue 11, p1115-1120, 6p |
| Abstrakt: |
Cardiovascular diseases (CVD) and malignant neoplasms (MN) are the main reasons of 70 % of death because of diseases in the developed countries. Success in treating MN has led to increased life expectancy of patients and accordingly increased the number of comorbide patients. It also should be noted that a great number of patients with malignant neoplasms or oncopathology have cardiovascular disease in their anamnesis, and as it was discovered, this disease is the main reason of death in patients recovered from oncological disease. The rate of the risks for the patient according to characteristics of the diseases and treatment, and close connection with oncologists are vitally necessary to determine the optimal strategies of treatment in this population. According to the above mentioned, the actuality of treatment cardiovascular pathology and prevention cardiotoxicity connected to chemotherapy of MN have become obvious. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
